4-(3-METHYL-5-OXO-1-PHENYL-4,5-DIHYDRO-1H-PYRAZOL-4-YLAZO)-BENZENESULFONAMIDE
UNII F64D20266I
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1h-pyrazol-4-ylazo)-benzenesulfonamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F64D20266I.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 32039-48-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H15N5O3S KUVBWHIBLGEIST-VHEBQXMUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1h-pyrazol-4-ylazo)-benzenesulfonamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.